Home >> Life Sciences >> Pharmaceuticals

Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 – 2020

Published: Apr-2016 | Format: PDF | Zion | Number of pages: 110 | Code: MRS - 53043


The report covers forecast and analysis for the depression drug market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the depression drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the depression drug market on a global level.

In order to give the users of this report a comprehensive view on the depression drug market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the depression drug market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the depression drug market by segmenting the market based class and region. The different classs of depression also have different symptoms, including major or clinical depressive disorder, postpartum depression, dysthymic disorder, psychotic depression and seasonal affective disorder. Depending upon class global depression drug market is segmented as anticonvulsants, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors (SSRIs), beta-blockers, benzodiazepines, tetracyclic antidepressants (TeCAs) and monoamine oxidase inhibitors (MAOIs) among others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Forest Laboratories, AstraZeneca, GlaxoSmithKline, Abbott Laboratories, H. Lundbeck, Novartis, SK Biopharmaceuticals, Naurex Merck & Co., and Eli Lilly and Company.

This report segments the global drug depression market as follows:

Global Depression Drug Market: Class Segment Analysis

  • Atypical Antipsychotics
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin-Norepinephrine Reuptake Inhibitors
  • Tetracyclic Antidepressants
  • Monoamine Oxidase inhibitors
  • Benzodiazepines
  • Others

Global Depression Drug Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2014 - 2020(USD Million)
    • 2.2. Global depression drug market: Snapshot
  • Chapter 3. Depression drug market – Global and Industry Analysis
    • 3.1. Depression drug: Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global depression drug market: Impact analysis
      • 3.2.2. Escalating prevalence of anxiety and depression disorders
      • 3.2.3. Rising efficiency and declining side effects of drugs in numerous classes
    • 3.3. Market restraints
      • 3.3.1. Restraints of global depression drug market: Impact analysis
      • 3.3.2. Expiry of main antidepressants
      • 3.3.3. Weak pipeline of new drugs
    • 3.4. Opportunities
      • 3.4.1. Small market penetration in developing countries
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by class segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Depression drug market - Competitive Landscape
    • 4.1. Company market share, 2014
    • 4.2. Price trend analysis
  • Chapter 5. Global Depression drug market : Class Overview
    • 5.1. Global depression drug market share, by class, 2014 and 2020
    • 5.2. Global depression drug market for atypical antipsychotics, 2014 - 2020 (USD Million)
    • 5.3. Global depression drug market for tricyclic antidepressants, 2014 - 2020 (USD Million)
    • 5.4. Global depression drug market for selective serotonin reuptake inhibitors, 2014 - 2020 (USD Million)
    • 5.5. Global depression drug market for tetracyclic antidepressants, 2014 – 2020 (USD Million)
    • 5.6. Global depression drug market for monoamine oxidase inhibitors, 2014 – 2020 (USD Million)
    • 5.7. Global depression drug market for benzodiazepines, 2014 – 2020 (USD Million)
    • 5.8. Global depression drug market for others, 2014 – 2020 (USD Million)
  • Chapter 6. Global Depression drug market – Regional Segment Analysis
    • 6.1. Global depression drug market : Regional overview
      • 6.1.1. Global depression drug market revenue share, by region, 2014 and 2020
    • 6.2. North America
      • 6.2.1. North America depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. depression drug market revenue, by class, 2014 – 2020 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.3.3. France
        • 6.3.3.1. France depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.3.4. UK
        • 6.3.4.1. U.K. depression drug market revenue, by class, 2014 – 2020 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India depression drug market revenue, by class, 2014 – 2020 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America depression drug market revenue, by class, 2014 – 2020 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil depression drug market revenue, by class, 2014 – 2020 (USD Million)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa depression drug market revenue, by class, 2014 – 2020 (USD Million)
  • Chapter 7. Company Profile
    • 7.1. Forest Laboratories
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. AstraZeneca
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Eli Lilly and Company
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. H. Lundbeck, Merck & Co.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. GlaxoSmithKline
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Naurex
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Novartis
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. SK Biopharmaceuticals
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments

List of Tables

1. Depression drug market : Market snapshot                                                            
2. Drivers of global depression drug market : Impact analysis
3. Restraints of global depression drug market : Impact analysis
4. North America depression drug market revenue, by class, 2014 – 2020 (USD Million)
5. U.S. depression drug market revenue, by class, 2014 – 2020 (USD Million)
6. Europe depression drug market revenue, by class, 2014 – 2020 (USD Million)
7. Germany depression drug market revenue, by class, 2014 – 2020 (USD Million)
8. France depression drug market revenue, by class, 2014 – 2020 (USD Million)
9. U.K. depression drug market revenue, by class, 2014 – 2020 (USD Million)
10. Asia Pacific depression drug market revenue, by class, 2014 – 2020 (USD Million)
11. China depression drug market revenue, by class, 2014 – 2020 (USD Million)
12. Japan depression drug market revenue, by class, 2014 – 2020 (USD Million)
13. India depression drug market revenue, by class, 2014 – 2020 (USD Million)
14. Latin America depression drug market revenue, by class, 2014 – 2020 (USD Million)
15. Brazil depression drug market revenue, by class, 2014 – 2020 (USD Million)
16. Middle East & Africa depression drug market revenue, by class, 2014 – 2020 (USD Million)


List of Figures

1. Market research process
2. Market research methodology
3. Global depression drug market revenue, 2014 - 2020 (USD Million)
4. Porter’s five forces analysis
5. Depression Drug : Market attractiveness analysis, by class segment
6. Company market share analysis, 2014 and 2020
7. Global depression drug market share, by class, 2014 and 2020
8. Global depression drug market for atypical antipsychotics, 2014 - 2020 (USD Million)
9. Global depression drug market for tricyclic antidepressants, 2014 - 2020 (USD Million)
10. Global depression drug market for selective serotonin reuptake inhibitors, 2014 - 2020 (USD Million)
11. Global depression drug market for tetracyclic antidepressants, 2014 – 2020 (USD Million)
12. Global depression drug market for monoamine oxidase inhibitors, 2014 – 2020 (USD Million)
13. Global depression drug market for benzodiazepines, 2014 – 2020 (USD Million)
14. Global depression drug market for others, 2014 – 2020 (USD Million)

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.  

Zion Research has collected key data related to the Depression Drug Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global Depression Drug Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Depression is an illness that leads to continual loss of interest and feeling of sadness. Clinical depression or depressive disorder affects the way someone feels, thinks and behaves and can cause several physical and emotional problems. The age group with the utmost rates of depression is below 20 years, with puberty being the usual age of beginning for depression. Depression is a very widespread illness, affecting among about 10% to 15% of men and 10% to 25% of women. Although depression affects individuals of all ages, around twice as many women as men are treated with clinical depression.

Major driver of the global depression drug market is the escalating prevalence of anxiety and depression disorders. Some of the key reasons driving depression drug market are growing geriatric population and rising effectiveness and declining side effects of drugs in numerous classes. However, drug resistant-mental disorders are likely to challenge the growth of the depression drug market. Regardless of this decline in sales high global prevalence of depression which is major reason of disability and small market penetration in a few areas, offer several opportunities.

Depression Drug Market

The different types of depression also have different symptoms, including major or clinical depressive disorder, postpartum depression, dysthymic disorder, psychotic depression and seasonal affective disorder. Depending upon class global depression drug market is segmented as anticonvulsants, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors (SSRIs), beta-blockers, benzodiazepines, tetracyclic antidepressants (TeCAs) and monoamine oxidase inhibitors (MAOIs) among others. SNRIs emerged as potential segment in 2014 and acquired more than 32% of the overall market share. However, it is estimated that this segment may exhibit decline in growth in the near future.

North America emerged as major regional market for the global depression in 2014. This dominance was mainly because of presence of large population infected with numerous kinds of depression and anxiety disorders. Currently, U.S. is saturated as a variety of antidepressant drugs are available on prescription for the similar symptom. Around 9% of the U.S. population suffers from depression. Globally less than 50% of depressed patients take treatment for depression. Every year an estimated around 1.5 million people or 1 in 20 Canadians, report several form of anxiety disorder or depression. In fact, about 1 in 10 women is expected to suffer postpartum depression in the month subsequent childbirth. In Asia Pacific strong economic growth in economies such as China, Japan, and Australia would contribute to the growth of the depression drug market.

Different industry participants in this market will benefit from the development of herbal remedies along with the improvements in the distribution network in promising economies. The key players operating in this market are Forest Laboratories, AstraZeneca, GlaxoSmithKline, Abbott Laboratories, H. Lundbeck, Merck & Co., and Eli Lilly and Company.


Related Reports

Global Ambidextrous Dental Units Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 164 | Code : MRS-141921 | 2600

In this report, we analyze the Ambidextrous Dental Units industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We Read more

Global Cysto-Nephroscope Video Endoscopes Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 154 | Code : MRS-141919 | 2600

In this report, we analyze the Cysto-Nephroscope Video Endoscopes industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to Read more

Global Drug Discovery Surface Plasmon Resonance Systems Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 165 | Code : MRS-141917 | 2600

In this report, we analyze the Drug Discovery Surface Plasmon Resonance Systems industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different region Read more

Global Indocyanine Green Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 162 | Code : MRS-141906 | 2600

In this report, we analyze the Indocyanine Green industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also ma Read more

Global Cosmetic Serum Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 159 | Code : MRS-141873 | 2600

In this report, we analyze the Cosmetic Serum industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make Read more

Global Continuous Syringe Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 150 | Code : MRS-141870 | 2600

In this report, we analyze the Continuous Syringe industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also m Read more

Global Health Watches Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 163 | Code : MRS-141866 | 2600

In this report, we analyze the Health Watches industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make Read more

Global Mini C-arm Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 151 | Code : MRS-141862 | 2600

In this report, we analyze the Mini C-arm industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a pr Read more

Global Artificial Acrylic Teeth Industry Market Research 2017

Jun-2017 | HJResearch | Pages : 164 | Code : MRS-141826 | 2600

In this report, we analyze the Artificial Acrylic Teeth industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We Read more

Global Pharmaceutical Grade Sodium Chloride Industry Market Research 2017

May-2017 | HJResearch | Pages : 146 | Code : MRS-141818 | 2600

In this report, we analyze the Pharmaceutical Grade Sodium Chloride industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 Read more

Single User | $(USD)4199 View Pricing